1. |
Wang X, Li J, Wang C, et al. The effects of mindfulness-based intervention on quality of life and poststroke depression in patients with spontaneous intracerebral hemorrhage in china. Int J Geriatr Psychiatry, 2020, 35(5): 572-580.
|
2. |
Renoux C, Vahey S, Dell’Aniello S, et al. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol, 2017, 74(2): 173-180.
|
3. |
Scheitz JF, Turc G, Kujala L, et al. Intracerebral hemorrhage and outcome after thrombolysis in stroke patients using selective serotonin-reuptake inhibitors. Stroke, 2017, 48(12): 3239-3244.
|
4. |
Liu L, Fuller M, Behymer TP, et al. Selective serotonin reuptake inhibitors and intracerebral hemorrhage risk and outcome. Stroke, 2020, 51(4): 1135-1141.
|
5. |
Marquez-Romero JM, Reyes- Martínez M, Huerta-Franco MR, et al. Fluoxetine for motor recovery after acute intracerebral hemorrhage, the FMRICH trial. Clin Neurol Neurosurg, 2020, 190: 105656.
|
6. |
Sanders J, Mayford M. Chronic fluoxetine dissociates contextual from auditory fear memory. Neurosci lett, 2016, 632: 152-156.
|
7. |
Li Q, Lan X, Han X, et al. Expression of Tmem119/Sall1 and Ccr2/CD69 in facs-sorted microglia- and monocyte/macrophage-enriched cell populations after intracerebral hemorrhage. Front Cell Neurosci, 2018, 12: 520.
|
8. |
Wu H, Wu T, Li M, et al. Efficacy of the lipid-soluble iron chelator 2, 2’-dipyridyl against hemorrhagic brain injury. Neurobiol Dis, 2012, 45(1): 388-394.
|
9. |
Kubiszewski P, Sugita L, Kourkoulis C, et al. Association of selective serotonin reuptake inhibitor use after intracerebral hemorrhage with hemorrhage recurrence and depression severity. JAMA Neurol, 2020, 78(1): 1-8.
|
10. |
Jensen MP, Ziff OJ, Banerjee G, et al. The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: a systematic review and meta-analysis. Eur Stroke J, 2019, 4(2): 144-152.
|
11. |
Tang WK, Chen Y, Liang H, et al. Cerebral microbleeds as a predictor of 1-year outcome of poststroke depression. Stroke, 2014, 45(1): 77-81.
|
12. |
Aarts N, Akoudad S, Noordam R, et al. Inhibition of serotonin reuptake by antidepressants and cerebral microbleeds in the general population. Stroke, 2014, 45(7): 1951-1957.
|
13. |
de Abajo FJ. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs Aging, 2011, 28(5): 345-367.
|
14. |
Carneiro AM, Cook EH, Murphy DL, et al. Interactions between integrin alphaiibbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest, 2008, 118(4): 1544-1552.
|
15. |
Deyama S, Bang E, Wohleb ES, et al. Role of neuronal VEGF signaling in the prefrontal cortex in the rapid antidepressant effects of ketamine. Am J Psychiatry, 2019, 176(5): 388-400.
|
16. |
Zhao C, Wang H, Xiong C, et al. Hypoxic glioblastoma release exosomal VEGF-A induce the permeability of blood-brain barrier. Biochem Biophys Res Commun, 2018, 502(3): 324-331.
|
17. |
Greene TK, Schiviz A, Hoellriegl W, et al. Towards a standardization of the murine tail bleeding model. J Thromb Haemost, 2010, 8(12): 2820-2822.
|
18. |
Medeiros GC, Roy D, Kontos N, et al. Post-stroke depression: a 2020 updated review. Gen Hosp Psychiatry, 2020, 66: 70-80.
|